Rausch Christian, Laflamme L, Bültmann U, Möller J
Department of Public Health Sciences, Karolinska Institutet, Widerströmska huset 4:th floor, Tomtebodavägen 18A, SE 17177, Stockholm, Sweden.
Department of Health Sciences, Community and Occupational Medicine, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 1, FA10, 9713 AV, Groningen, The Netherlands.
Eur J Clin Pharmacol. 2017 Jun;73(6):743-749. doi: 10.1007/s00228-017-2220-8. Epub 2017 Mar 9.
This national, population-based study aims to determine the association between the number of prescribed medications and adverse drug events (ADE) by unintentional poisoning and examine this risk when known indicators of inappropriate drug use (IDU) are accounted for.
We employed a matched case-control design among people living in Sweden who were 50 years and older. Cases experiencing an ADE by unintentional poisoning resulting in hospitalization or death (n = 5336) were extracted from the National Health and Death Registers from January 2006 to December 2009. Four controls per case matched by age, sex and residential area were randomly selected among those without an ADE (n = 21,344). Prescribed medications dispensed during the 4-month period prior to the ADE were identified via the Swedish Prescribed Drug Register and coded according to the number of different dispensed medications (NDDM) (0 to 10 medications) and IDU indicators (one single-drug, and three drug-combinations). Conditional logistic regression was used.
Each of the IDU indicators was significantly associated with very high risks of ADE. For NDDM, we found a lower but graded positive association from two to ten or more medications (adjusted OR, 1.5; 95% CI, 1.2-1.8). Exclusion of IDU from the NDDM decreased the risk of ADE, but the effects remained significant for three or more medications (adjusted OR excl. IDU, 1.5; 95% CI, 1.2-2.0).
At population level, the number of different dispensed medications starting from three or more remains associated with ADE even after adjusting for known IDUs. Clinicians and patients need to be made aware of the increased likelihood of serious ADE, not only in case of documented inappropriate medications but also in the case of an increasing number of medications.
这项基于全国人口的研究旨在确定所开药物数量与非故意中毒导致的药物不良事件(ADE)之间的关联,并在考虑已知的不适当用药指标(IDU)时检查这种风险。
我们在瑞典50岁及以上的人群中采用了匹配病例对照设计。2006年1月至2009年12月期间,从国家卫生和死亡登记册中提取因非故意中毒导致住院或死亡的ADE病例(n = 5336)。在无ADE的人群中(n = 21344),按照年龄、性别和居住地区为每个病例随机选取4名对照。通过瑞典处方药登记册确定在ADE发生前4个月内发放的处方药,并根据不同发放药物的数量(NDDM)(0至10种药物)和IDU指标(一种单一药物和三种药物组合)进行编码。使用条件逻辑回归分析。
每个IDU指标都与ADE的极高风险显著相关。对于NDDM,我们发现从两种药物到十种或更多药物存在较低但分级的正相关(调整后的OR为1.5;95% CI为1.2 - 1.8)。从NDDM中排除IDU可降低ADE风险,但对于三种或更多药物,这种影响仍然显著(排除IDU后的调整后OR为1.5;95% CI为1.2 - 2.0)。
在人群层面,即使在调整已知的IDU后,从三种或更多不同发放药物数量开始仍与ADE相关。临床医生和患者需要意识到严重ADE发生可能性增加,不仅在有记录的不适当用药情况下,而且在药物数量增加的情况下。